Sex and age difference in risk factor distribution, trend, and long-term outcome of patients undergoing isolated coronary artery bypass graft surgery
Tóm tắt
Preoperative coronary artery disease risk factors (CADRFs) distribution and pattern may also have an important role in determining major adverse cardiovascular events (MACEs). In this study, we aimed to evaluate the CADRFs distribution and trend over 10 years and also the long-term outcome of CABG in different age-sex categories. In this registry-based serial cross-sectional study, we enrolled 24,328 patients who underwent isolated CABG and evaluated the prevalence of CADRFs according to sex and age. We used inverse probability weighting (IPW) to compare survival and MACE between the sexes. We also used Cox regression to determine each CADRFs effect on survival and MACEs. In general, DLP (56.00%), HTN (53.10%), DM (38.40%), and positive family history (38.30%) were the most frequent risk factors in all patients. Prevalence of HTN, DLP, DM, obesity, and positive family history were all higher in women, all statistically significant. The median follow-up duration was 78.1 months (76.31–79.87 months). After inverse probability weighting (to balance risk factors and comorbidities), men had lower MACEs during follow-up (HR 0.72; 95% CI 0.57–0.91; P value 0.006) and there was no significant difference in survival between sexes. DM and HTN were associated with higher mortality and MACEs in both sexes. Although DLP is still the most frequent CADRF among the CABG population, the level of LDL and TG is decreasing. Women experience higher MACE post CABG. Therefore, health care providers and legislators must pay greater attention to female population CADRFs and ways to prevent them at different levels.
Tài liệu tham khảo
Okrainec K, Banerjee DK, Eisenberg MJJAHJ. Coronary artery disease in the developing world. Am Heart J. 2004;148(1):7–15.
Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A-M, Pajak AJC. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90(1):583–612.
Melly L, Torregrossa G, Lee T, Jansens J-L, Puskas JDJJOTD. Fifty years of coronary artery bypass grafting. J Thoracic Disease. 2018;10(3):1960.
Matkovic M, Tutus V, Bilbija I, Lazovic JM, Savic M, Cubrilo M, et al. Long term outcomes of the off-pump and on-pump coronary artery bypass grafting in a high-volume center. Sci Rep. 2019;9(1):8567.
Kannel WB, McGee D, Gordon TJTJOC. A general cardiovascular risk profile: the Framingham study. Am J Cardiol. 1976;38(1):46–51.
Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): a case-control study. The Lancet. 2004;364(9438):937–52.
Leifheit-Limson EC, D’Onofrio G, Daneshvar M, Geda M, Bueno H, Spertus JA, et al. Sex differences in cardiac risk factors, perceived risk, and health care provider discussion of risk and risk modification among young patients with acute myocardial infarction: the VIRGO study. J Am College Cardiol. 2015;66(18):1949–57.
den Ruijter HM, Haitjema S, van der Meer MG, Van der Harst P, Rouleau JL, Asselbergs FW, et al. Long-term outcome in men and women after CABG; results from the IMAGINE trial. Atherosclerosis. 2015;241(1):284–8.
Nicolini F, Fortuna D, Contini GA, Pacini D, Gabbieri D, Zussa C, et al. The impact of age on clinical outcomes of coronary artery bypass grafting: long-term results of a real-world registry. BioMed Res. 2017. https://doi.org/10.1155/2017/9829487.
Poorhosseini H, Abbasi SH. The Tehran heart center. Eur Heart J. 2018;39(29):2695–6.
Vikulova DN, Grubisic M, Zhao Y, Lynch K, Humphries KH, Pimstone SN, Brunham LR. Premature atherosclerotic cardiovascular disease: trends in incidence, risk factors, and sex-related differences, 2000 to 2016. J Am Heart Assoc. 2019. https://doi.org/10.1161/jaha.119.012178.
Cornwell LD, Omer S, Rosengart T, Holman WL, Bakaeen FGJJS. Changes over time in risk profiles of patients who undergo coronary artery bypass graft surgery: the Veterans Affairs Surgical Quality Improvement Program (VASQIP). JAMA Surg. 2015;150(4):308–15.
ElBardissi AW, Aranki SF, Sheng S, O’Brien SM, Greenberg CC, Gammie JSJTJOT, et al. Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg. 2012;143(2):273–81.
Vikulova DN, Grubisic M, Zhao Y, Lynch K, Humphries KH, Pimstone SN, et al. Premature atherosclerotic cardiovascular disease: trends in incidence, risk factors, and sex-related differences, 2000 to 2016. J Am Heart Assoc. 2019;8(14):e012178.
Pathak LA, Shirodkar S, Ruparelia R, Rajebahadur J. Coronary artery disease in women. Indian Heart J. 2017;69(4):532–8. https://doi.org/10.1016/j.ihj.2017.05.023.
Keteepe-Arachi T, Sharma S. Cardiovascular disease in women: understanding symptoms and risk factors. Eur Cardiol. 2017;12(1):10–3. https://doi.org/10.15420/ecr.2016:32:1.
Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, et al. Metabolic health in the Middle East and North Africa. Lancet Diabetes Endocrinol. 2019;7(11):866–79.
Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):1–10.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–50.
Hamid M, Mojtaba L, Afshin O, Farzad H, Fereidoun A, Moein Y, et al. Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007–2016. Sci Rep. 2020;10(1):1–10.
Charrois TL, Zolezzi M, Koshman SL, Pearson G, Makowsky M, Durec T, et al. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacother: J Hum Pharmacol Drug Therapy. 2012;32(3):222–33.
Yousufuddin M, Zhu Y, Al Ward R, et al. Association of hyperlipidaemia with 5-year survival after hospitalisation for acute myocardial infarction: a propensity score matched analysis. Open Heart. 2020;7:e001163. https://doi.org/10.1136/openhrt-2019-001163.
Antunes PE, de Oliveira JF, Antunes MJJE. Coronary surgery in patients with diabetes mellitus: a risk-adjusted study on early outcome. Eur J Cardio-Thoracic Surg. 2008;34(2):370–5.
Naito R, Miyauchi KJIHJ. Coronary artery disease and type 2 diabetes mellitus current treatment strategies and future perspective. Int Heart J. 2017. https://doi.org/10.1536/ihj.17-191.
Van Straten AH, Soliman Hamad MA, van Zundert AA, Martens EJ, Schönberger JP, ter Woorst JF, et al. Diabetes and survival after coronary artery bypass grafting: comparison with an age-and sex-matched population. Eur J Cardio-Thoracic Surg. 2010;37(5):1068–74.
Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first Nationwide diabetes report of National Program for prevention and control of diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461. https://doi.org/10.1038/s41598-017-13379-z.
Preisler Y, Ziv-Baran T, Chorin E, Margolis G, Khoury S, Shacham Y. Family history of coronary artery disease and adverse clinical outcomes in patients suffering from acute ST-segment elevation myocardial infarction. Coron Artery Dis. 2018;29:657–62.
Ruttmann E, Abfalterer H, Dietl M, Wagner J, Kilo J, Grimm M, et al. Positive family history of cardiovascular disease and long-term outcomes after coronary artery bypass grafting: a genetic paradox? Eur J Cardio-Thoracic Surg. 2020;57(5):986–93.
Liu X, Xie L, Zhu W, Zhou YJN. Association of body mass index and all-cause mortality in patients after cardiac surgery: a dose-response meta-analysis. PeerJ. 2020;72:110696.
Benedetto U, Danese C, Codispoti MJTJOT. Obesity paradox in coronary artery bypass grafting: myth or reality? J Thoracic Cardiovasc Surg. 2014;147(5):1517–23.
Carbone S, Canada JM, Billingsley HE, Siddiqui MS, Elagizi A, Lavie CJ. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89–100.
Moosazadeh M, Ziaaddini H, Mirzazadeh A, Ashrafi-Asgarabad A, Haghdoost AA. Meta-analysis of smoking prevalence in Iran. Addict Health Summer Autumn. 2013;5(3–4):140–53.
Aittokallio J, Palmu J, Niiranen TJEJOPC. Smoking is the strongest modifiable risk factor for mortality post coronary revascularization. Eur J Prevent Cardiol. 2019;27:2308–10.
Masoudkabir F, Yavari N, Pashang M, Sadeghian S, Jalali A, Poorhosseini H, et al. Effect of persistent opium consumption after surgery on the long-term outcomes of surgical revascularization. Eur J Prevent Cardiol. 2020;27(18):1996–2003.
Habibi M, Alipour A, Soleimani A, Kiabi F, Habibi A, Zeydi AJB. The effect of opium addiction on short-term postoperative outcomes after coronary artery bypass graft surgery: a prospective observational cohort study. Biomedicine. 2020;10(4):23–8.
Sadeghian S, Karimi A, Dowlatshahi S, Ahmadi SH, Davoodi S, Marzban M, et al. The association of opium dependence and postoperative complications following coronary artery bypass graft surgery: a propensity-matched study. J Opioid Manag. 2009;5(6):365–72.